- Home
- MORN vs QGEN Comparison
MORN vs QGEN Comparison
Compare MORN & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MORN | QGEN |
|---|---|---|
| Founded | 1984 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 8.5B |
| IPO Year | 2004 | 1998 |
Fundamental Metrics
Financial Performance| Metric | MORN | QGEN |
|---|---|---|
| Price | $201.07 | $42.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $256.50 | $45.76 |
| AVG Volume (30 Days) | 374.6K | ★ 2.7M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | 1.07% | ★ 7.17% |
| EPS Growth | ★ 3.38 | N/A |
| EPS | ★ 5.55 | N/A |
| Revenue | ★ $2,445,500,000.00 | N/A |
| Revenue This Year | $9.14 | $8.18 |
| Revenue Next Year | $7.23 | $5.71 |
| P/E Ratio | $35.84 | ★ $24.01 |
| Revenue Growth | ★ 7.49 | N/A |
| 52 Week Low | $141.49 | $32.53 |
| 52 Week High | $266.05 | $57.82 |
Technical Indicators
Market Signals| Indicator | MORN | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout MORN Morningstar Inc.
Morningstar Inc is a provider of independent investment insights to financial advisers, asset managers, and investors. It provides data and research insights on various investment offerings, including managed investment products, publicly listed companies, private capital markets, debt securities, and real-time market data. The company has five reportable segments: Morningstar Direct Platform, PitchBook, Morningstar Credit, Morningstar Wealth, and Morningstar Retirement. Maximum revenue is derived from the Morningstar Direct Platform, which provides investors with comprehensive data, research, insights, and investment analysis through product areas such as Morningstar Data, Morningstar Direct, and Morningstar Advisor Workstation. Geographically, it generates maximum revenue from the USA.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).